KR20120071932A - Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity - Google Patents
Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity Download PDFInfo
- Publication number
- KR20120071932A KR20120071932A KR1020100133670A KR20100133670A KR20120071932A KR 20120071932 A KR20120071932 A KR 20120071932A KR 1020100133670 A KR1020100133670 A KR 1020100133670A KR 20100133670 A KR20100133670 A KR 20100133670A KR 20120071932 A KR20120071932 A KR 20120071932A
- Authority
- KR
- South Korea
- Prior art keywords
- lactic acid
- parts
- weight
- composition
- fermentation
- Prior art date
Links
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 title claims abstract description 80
- 235000014655 lactic acid Nutrition 0.000 title claims abstract description 40
- 239000004310 lactic acid Substances 0.000 title claims abstract description 40
- 230000003078 antioxidant effect Effects 0.000 title claims abstract description 32
- 230000003276 anti-hypertensive effect Effects 0.000 title claims abstract description 24
- 241000196324 Embryophyta Species 0.000 title description 9
- 238000000855 fermentation Methods 0.000 claims abstract description 49
- 230000004151 fermentation Effects 0.000 claims abstract description 49
- 239000000203 mixture Substances 0.000 claims abstract description 44
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims abstract description 37
- 240000006891 Artemisia vulgaris Species 0.000 claims abstract description 27
- 240000006024 Lactobacillus plantarum Species 0.000 claims abstract description 18
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims abstract description 18
- 229940072205 lactobacillus plantarum Drugs 0.000 claims abstract description 18
- 235000000346 sugar Nutrition 0.000 claims abstract description 12
- 244000025254 Cannabis sativa Species 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 6
- 241000218206 Ranunculus Species 0.000 claims description 24
- 235000013305 food Nutrition 0.000 claims description 24
- 241000894006 Bacteria Species 0.000 claims description 22
- 230000002708 enhancing effect Effects 0.000 claims description 18
- 239000004480 active ingredient Substances 0.000 claims description 16
- 235000013311 vegetables Nutrition 0.000 claims description 11
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 claims description 10
- 235000003097 Artemisia absinthium Nutrition 0.000 claims description 10
- 240000001851 Artemisia dracunculus Species 0.000 claims description 10
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 claims description 10
- 239000001138 artemisia absinthium Substances 0.000 claims description 10
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 10
- 241000218201 Ranunculaceae Species 0.000 claims description 6
- 239000003963 antioxidant agent Substances 0.000 abstract description 20
- 235000006708 antioxidants Nutrition 0.000 abstract description 19
- 230000000694 effects Effects 0.000 abstract description 8
- 238000002156 mixing Methods 0.000 abstract description 3
- 241000527163 Aster scaber Species 0.000 abstract 1
- 235000005276 Doellingeria scabra Nutrition 0.000 abstract 1
- 240000008881 Oenanthe javanica Species 0.000 abstract 1
- 235000000365 Oenanthe javanica Nutrition 0.000 abstract 1
- UUUHXMGGBIUAPW-UHFFFAOYSA-N 1-[1-[2-[[5-amino-2-[[1-[5-(diaminomethylideneamino)-2-[[1-[3-(1h-indol-3-yl)-2-[(5-oxopyrrolidine-2-carbonyl)amino]propanoyl]pyrrolidine-2-carbonyl]amino]pentanoyl]pyrrolidine-2-carbonyl]amino]-5-oxopentanoyl]amino]-3-methylpentanoyl]pyrrolidine-2-carbon Chemical compound C1CCC(C(=O)N2C(CCC2)C(O)=O)N1C(=O)C(C(C)CC)NC(=O)C(CCC(N)=O)NC(=O)C1CCCN1C(=O)C(CCCN=C(N)N)NC(=O)C1CCCN1C(=O)C(CC=1C2=CC=CC=C2NC=1)NC(=O)C1CCC(=O)N1 UUUHXMGGBIUAPW-UHFFFAOYSA-N 0.000 description 22
- 102000004270 Peptidyl-Dipeptidase A Human genes 0.000 description 22
- 108090000882 Peptidyl-Dipeptidase A Proteins 0.000 description 22
- 238000011081 inoculation Methods 0.000 description 22
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
- 241000186660 Lactobacillus Species 0.000 description 14
- 229940039696 lactobacillus Drugs 0.000 description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 230000001953 sensory effect Effects 0.000 description 10
- 239000000243 solution Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 238000002835 absorbance Methods 0.000 description 7
- 235000008216 herbs Nutrition 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 206010020772 Hypertension Diseases 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 238000001784 detoxification Methods 0.000 description 5
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 150000001720 carbohydrates Chemical class 0.000 description 4
- 235000014633 carbohydrates Nutrition 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 102000015427 Angiotensins Human genes 0.000 description 3
- 108010064733 Angiotensins Proteins 0.000 description 3
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 229930003268 Vitamin C Natural products 0.000 description 3
- 230000036772 blood pressure Effects 0.000 description 3
- FAKRSMQSSFJEIM-RQJHMYQMSA-N captopril Chemical compound SC[C@@H](C)C(=O)N1CCC[C@H]1C(O)=O FAKRSMQSSFJEIM-RQJHMYQMSA-N 0.000 description 3
- 229960000830 captopril Drugs 0.000 description 3
- 206010012601 diabetes mellitus Diseases 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 230000001965 increasing effect Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 229940124595 oriental medicine Drugs 0.000 description 3
- 150000003254 radicals Chemical class 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019154 vitamin C Nutrition 0.000 description 3
- 239000011718 vitamin C Substances 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- BVCOHOSEBKQIQD-UHFFFAOYSA-N 2-tert-butyl-6-methoxyphenol Chemical compound COC1=CC=CC(C(C)(C)C)=C1O BVCOHOSEBKQIQD-UHFFFAOYSA-N 0.000 description 2
- BKZXZGWHTRCFPX-UHFFFAOYSA-N 2-tert-butyl-6-methylphenol Chemical compound CC1=CC=CC(C(C)(C)C)=C1O BKZXZGWHTRCFPX-UHFFFAOYSA-N 0.000 description 2
- 235000003129 Ambrosia artemisiifolia var elatior Nutrition 0.000 description 2
- 241001465677 Ancylostomatoidea Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000281762 Chenopodium ambrosioides Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 241000209504 Poaceae Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 230000002292 Radical scavenging effect Effects 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000003484 annual ragweed Nutrition 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000002790 anti-mutagenic effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 235000006263 bur ragweed Nutrition 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 235000021466 carotenoid Nutrition 0.000 description 2
- 150000001747 carotenoids Chemical class 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000005515 coenzyme Substances 0.000 description 2
- 235000003488 common ragweed Nutrition 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 235000021107 fermented food Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 235000015203 fruit juice Nutrition 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000002439 hemostatic effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 239000008057 potassium phosphate buffer Substances 0.000 description 2
- 230000003389 potentiating effect Effects 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000009736 ragweed Nutrition 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 239000005541 ACE inhibitor Substances 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-ZVIOFETBSA-N Aldosterone Chemical compound C([C@@]1([C@@H](C(=O)CO)CC[C@H]1[C@@H]1CC2)C=O)[C@H](O)[C@@H]1[C@]1(C)C2=CC(=O)CC1 PQSUYGKTWSAVDQ-ZVIOFETBSA-N 0.000 description 1
- PQSUYGKTWSAVDQ-UHFFFAOYSA-N Aldosterone Natural products C1CC2C3CCC(C(=O)CO)C3(C=O)CC(O)C2C2(C)C1=CC(=O)CC2 PQSUYGKTWSAVDQ-UHFFFAOYSA-N 0.000 description 1
- 102000004881 Angiotensinogen Human genes 0.000 description 1
- 108090001067 Angiotensinogen Proteins 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 229930188701 Astersaponin Natural products 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 101800004538 Bradykinin Proteins 0.000 description 1
- 102400000967 Bradykinin Human genes 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 1
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000483021 Cucullia absinthii Species 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- QXZGBUJJYSLZLT-UHFFFAOYSA-N H-Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg-OH Natural products NC(N)=NCCCC(N)C(=O)N1CCCC1C(=O)N1C(C(=O)NCC(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CO)C(=O)N2C(CCC2)C(=O)NC(CC=2C=CC=CC=2)C(=O)NC(CCCN=C(N)N)C(O)=O)CCC1 QXZGBUJJYSLZLT-UHFFFAOYSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 206010019837 Hepatocellular injury Diseases 0.000 description 1
- MMFKFJORZBJVNF-UWVGGRQHSA-N His-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@@H](N)CC1=CN=CN1 MMFKFJORZBJVNF-UWVGGRQHSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229920002230 Pectic acid Polymers 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 240000009164 Petroselinum crispum Species 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 108090000783 Renin Proteins 0.000 description 1
- 102100028255 Renin Human genes 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 231100000354 acute hepatitis Toxicity 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229960002478 aldosterone Drugs 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 229940044094 angiotensin-converting-enzyme inhibitor Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000003178 anti-diabetic effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000000767 anti-ulcer Effects 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- QXZGBUJJYSLZLT-FDISYFBBSA-N bradykinin Chemical compound NC(=N)NCCC[C@H](N)C(=O)N1CCC[C@H]1C(=O)N1[C@H](C(=O)NCC(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CO)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)CCC1 QXZGBUJJYSLZLT-FDISYFBBSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 235000009120 camo Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000005607 chanvre indien Nutrition 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 150000001893 coumarin derivatives Chemical class 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 230000006806 disease prevention Effects 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 210000003989 endothelium vascular Anatomy 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 239000011487 hemp Substances 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 108010025306 histidylleucine Proteins 0.000 description 1
- 239000003864 humus Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000008991 intestinal motility Effects 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- -1 maltose and sucrose Chemical compound 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 1
- 235000011197 perejil Nutrition 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 239000010318 polygalacturonic acid Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229910052594 sapphire Inorganic materials 0.000 description 1
- 239000010980 sapphire Substances 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 239000013049 sediment Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/169—Plantarum
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Description
본 발명은 쑥, 취나물 및 미나리로 이루어진 군으로부터 선택되는 하나 이상의 산야초에 유산균을 접종한 후 발효시켜 제조된 유산발효액을 유효성분으로 함유하는 항산화 활성 증진 또는 항고혈압 활성 증진용 조성물 및 상기 조성물을 유효성분으로 함유하는 항산화 활성 증진 또는 항고혈압 활성 증진용 식품에 관한 것이다.The present invention is effective to increase the antioxidant activity or antihypertensive activity composition and the composition containing an lactic acid fermentation solution prepared by inoculating the lactic acid bacteria to one or more wild grasses selected from the group consisting of mugwort, wormwood and parsley as an active ingredient The present invention relates to a food for enhancing antioxidant activity or enhancing antihypertensive activity, as an ingredient.
국내에서 자생하고 있는 식물자원 중에서 식, 약용식물은 약 120과 350속으로 이 중에서 산채류는 320여종으로 지역적으로도 전국에 걸쳐 고루 분포하고 있다. 녹황색 채소류를 비롯한 각종 산야초류들은 각종 비타민류, 무기물류, 색소류 및 각종 특수성분 등의 중요한 영양소를 풍부하게 함유하고 있어 건강의 유지, 개선 및 질병예방에 크게 기여하고 있다. 그러나 대부분의 식물자원은 다량의 수분을 함유하고 있어 저장성이 취약하기 때문에 저장성과 기능성 향상을 위한 식품가공이 필요하다.Among the plant resources growing in Korea, food and medicinal plants are about 120 and 350 genera, among which 320 kinds of wild vegetables are distributed evenly throughout the country. Various green vegetables such as green and yellow vegetables are rich in important nutrients such as various vitamins, minerals, pigments and various special ingredients, thus contributing greatly to the maintenance, improvement and prevention of diseases. However, since most plant resources contain a large amount of water, storage is vulnerable, and thus food processing is required to improve shelf life and functionality.
쑥은 번식력이 강한 다년생 식물로서 약 2,000여종이 있으며 우리나라 자생종만도 300여종이나 알려져 있다. 쑥은 독특한 맛과 향으로 인하여 여러 가지 형태의 식품 재료로 이용되어 오고 있다. 쑥잎의 독특한 향기는 치네올이라는 정유 성분이며, 쑥떡이나 쑥버무리에 첨가되는 쑥은 떡의 산성을 중화하고 영양적인 보완을 하여 고른 영양 섭취를 가능케 해준다. 쑥은 예로부터 구황식품으로 이용되어 온 장수식품으로 단백질이 5%나 함유되어 있는 고단백 채소이다. 이 외에도 필수지방산, 당질, 비타민 C, β-카로틴, 철분, 칼슘의 함량이 비교적 높은 편으로, 잎에는 정유가 약 0.02% 포함되어 있으며, 아데닌 0.02%, 콜린 0.11%, 비타민 A, B, D 등이 함유되어 있다. 특히, 쑥은 무기질과 비타민 C가 많아 쑥을 자주 먹게 되면 몸의 저항력을 높여 주어 감기 예방과 치료에 효과적이다. 쑥은 한방에서 지혈약으로 사용될 뿐 아니라 소화, 구충, 악취 제거와 위장병, 변비, 신경통, 천식, 부인병 등에 효과가 있다고 알려져 있다. 쑥의 연한 잎을 말려서 찐 다음 즙을 만들어 마시면 해열과 진통, 해독, 구충, 혈압강하, 소염작용 효과를 볼 수 있다. 쑥잎을 애엽이라고 하는데, 한방에서는 복통, 토사, 출혈의 치료와 평상시 인체 내의 백혈구 수를 2~3배 가까이 늘려서 면역 기능을 높이는 쑥뜸으로 이용한다. 또한, 쑥은 예로부터 동맥경화, 고혈압, 당뇨병과 같은 노화관련 질환을 예방하는 효능이 있는 것으로 알려져 있으며, 최근 쑥에 대한 연구로 쑥의 인체내 항균, 항돌연변이, 항산화, 항당뇨, 항염증, 항위궤양, 항암 작용뿐만 아니라 흰쥐의 간과 혈청 중 중성지방 및 지질의 억제작용, 간세포 손상에 대한 방지작용 등이 시험을 통해 확인된 바 있다.Mugwort is a perennial plant with strong fertility and has about 2,000 species, and only 300 native species are known in Korea. Mugwort has been used in various forms of food because of its unique taste and aroma. The unique scent of mugwort leaves is an essential oil called cineol, and mugwort added to mugwort rice cakes and wormwood moths neutralizes the acidity of rice cakes and provides a nutritional supplement to enable even nutrition. Mugwort is a long-lived food that has been used as a guowang food since ancient times and is a high protein vegetable containing 5% protein. In addition, essential fatty acids, sugars, vitamin C, β-carotene, iron, calcium content is relatively high, the leaves contain about 0.02% essential oil, adenine 0.02%, choline 0.11%, vitamins A, B, D Etc. are contained. In particular, mugwort has a lot of minerals and vitamin C, so eating mugwort often increases the body's resistance and is effective in preventing and treating colds. Mugwort is not only used as a hemostatic drug in oriental medicine, but it is also known to be effective in digestion, hookworm, odor removal and gastrointestinal diseases, constipation, neuralgia, asthma and women's diseases. Dry and steam the soft leaves of mugwort and make juice to see the effects of fever, pain relief, detoxification, hookworm, lowering blood pressure, and anti-inflammatory effects. Mugwort leaves are called larvae. In oriental medicine, abdominal pain, sediment, and bleeding are usually used to increase the number of white blood cells in the human body by 2-3 times. In addition, mugwort has long been known to be effective in preventing aging-related diseases such as arteriosclerosis, hypertension and diabetes mellitus. Recent studies on mugwort have shown that antibacterial, antimutagenic, antioxidant, antidiabetic, anti-inflammatory, In addition to anti-ulcer and anti-cancer effects, tests have been shown to inhibit triglycerides and lipids in liver and serum of rats and to prevent hepatocellular damage.
취나물은 산채류를 대표하는 식물로서 우리나라 자생종은 60여 종이고 식용이 가능한 것은 24종이 있다. 우리나라에서 재배되고 있는 취나물은 참취, 개미취, 각시취, 곰취, 미역취, 청옥취, 수리취 등이 있는데, 그 중에서 참취가 향기가 독특하고 수확량이 많기 때문에 농가에서 많이 재배하고 있다. 취나물은 자연 상태에서는 30% 정도 차광이 되는 시원한 반음지에서 잘 자라며 부식질이 풍부하면서 습도 유지가 잘되면서 물 빠짐도 잘되는 토양에서 잘 자란다. 취나물은 맛과 향기가 뛰어나고 탄수화물, 비타민 A 등 다양한 영양분이 함유되어 있어 묵나물, 튀김, 부침용으로 이용되며 감기, 두통, 진통, 해독, 항암 등에 효과가 있어 한약재로도 이용된다. 취나물에는 비타민 A의 모체가 되는 카로틴과 비타민 B 복합체가 있고, 칼슘과 철분 등을 비교적 골고루 가지고 있는 알칼리성 식품이다. 취나물 중의 비타민 C가 알코올 분해에 도움을 주며, 비타민 B2는 간의 해독작용을 도와주기도 한다. 전초에는 쿠에르세틴, 아스테르사포닌, 정유가 들어 있고 꽃에는 많은 플라보노이드와 카로티노이드가 있다. 뿌리에는 트리테르페노이드와 쿠마린 화합물과 정유가 들어 있다. 특히 천식, 각혈, 폐결핵성 기침, 만성기관지염을 앓는 사람이 복용하면 효과를 본다. 취나물은 쓴맛이 강하므로 삶아서 여러 날 우려내어 나물로 무쳐 먹어야 한다. 또한, 취나물을 달여서 지속적으로 마시면 당뇨병에 좋고, 또한 진통, 해독, 혈액순환촉진 작용이 있어 두통을 비롯한 요통, 근골통증, 장염으로 인한 복통, 인후염에 효과가 있다. 이 외에도 취나물의 생리활성으로는 항산화 및 항균활성이 보고된 바 있다. Shunmul is a representative plant of wild vegetables. There are about 60 species of native plants in Korea, and 24 kinds of edible vegetables are available. The odorous cultivated in Korea includes scent, ant odor, horn horn, bear odor, seaweed odor, sapphire odor, squirt odor, etc. Among them, tuna is cultivated in farmhouses because of its unique fragrance and high yield. Munaeng grows well in cool halftones that are about 30% shading in nature, and grows well in soil that is rich in humus and well maintained with good humidity. Shunna has excellent taste and aroma, and contains various nutrients such as carbohydrates and vitamin A. It is used for muknamul, fry and ups and downs. It is also used as a herbal medicine because it is effective for colds, headaches, pain, detoxification and anticancer. Dried sprouts contain carotene and vitamin B complexes, which are the mother of vitamin A, and are relatively alkaline foods containing calcium and iron. Vitamin C in medicinal herbs helps to break down alcohol, and vitamin B 2 may also help the liver in detoxification. Outpost contains quercetin, astersaponin, essential oils, and flowers contain many flavonoids and carotenoids. The root contains triterpenoids, coumarin compounds and essential oils. In particular, people who have asthma, bleeding, pulmonary tuberculosis cough, or chronic bronchitis will benefit. Drunken herbs have a strong bitter taste, so boil them for several days and eat them with herbs. In addition, the continuous drinking of drunk herbs is good for diabetes, and also has analgesic, detoxification, and blood circulation promoting action, it is effective in headache, back pain, myalgia, stomach pain due to enteritis, sore throat. In addition, the physiological activity of medicinal herbs has been reported to have antioxidant and antimicrobial activity.
미나리는 다습한 땅이나 물이 흐르는 곳에서 자생하는 산형과의 다년생 초본으로 물기가 있는 곳이나 냇가에서 자라는 호습성으로 한방에서는 수영, 수근이라고도 한다. 원산지는 중국 북부지방으로 동남아시아 일대에 걸쳐 광범위하게 분포하고 있으며, 중국에서는 이미 기원 전 2천년 경부터 논미나리, 밭미나리를 재배했다고 알려져 있을 정도로 식품으로서 오랫동안 상용된 식물이다. 미나리는 신선한 빛깔과 특유의 방향을 지니고 있으므로 미각을 돋구는 채소로 이용되어 왔으며 식용뿐만 아니라 오래전부터 민간요법이나 한방에서 숙취제거, 이뇨작용, 간경변 억제작용, 혈중 콜레스테롤 저하작용, 해독작용, 지혈작용 등의 여러 약리작용을 지니고 있어, 물고기 중독, 혈뇨, 자궁출혈, 고혈압, 불면증 등 여러 질병의 치료에 다양하게 응용되어 왔다. 특히 급만성 간염의 치료에 효과적인 것으로 알려져 있다. 최근에는 미나리 추출물의 간기능 회복, 항산화, 항돌연변이 작용과 함께 위암세포의 성장억제 효과 등이 보고된 바 있다. Buttercup is a perennial herb that grows in humid lands and waters, and is known for its hygroscopicity that grows in waters and streams. Originated from northern China, and widely distributed throughout Southeast Asia, it is a plant that has been widely used as a food for a long time. Buttercup has a fresh color and unique aroma, so it has been used as a tasteful vegetable and has been used not only for food but also for a long time in folk remedies or oriental medicine for hangover removal, diuretic effect, liver cirrhosis suppression, blood cholesterol lowering effect, detoxification effect, hemostatic effect, etc. Because of its many pharmacological effects, it has been applied to various diseases such as fish poisoning, hematuria, uterine bleeding, hypertension, insomnia, etc. It is known to be particularly effective in the treatment of acute hepatitis. Recently, it has been reported that the buttercup extract has liver function recovery, antioxidant activity, and antimutagenic activity of gastric cancer cells.
발효식품은 식품 저장성이 우수하여 보존성과 위생상 안전성이 확보되는 경제적인 식품이다. 식품을 발효함으로써 고분자 물질이 저분자 물질로 분해되어 소화 흡수율을 높이고, 새로운 풍미 생성으로 기호성이 증대될 뿐만 아니라 생리활성을 갖는 성분이 생성되어, 최근에는 발효식품에서 3차 기능 효과가 있는 유용한 물질 탐색 및 발효대사의 연구가 활발하게 진행되고 있다.Fermented foods are economic foods that have good food storage properties and ensure preservation and hygiene safety. By fermenting foods, high-molecular substances are decomposed into low-molecular substances to increase digestion and absorption, new flavors increase palatability, and biologically active ingredients are produced. Recently, useful substances with tertiary functional effects are found in fermented foods. And fermentation metabolism is actively researched.
고혈압은 전세계적으로 성인의 15~20%가 앓고 있는 질병으로 동맥경화, 뇌졸중, 심근경색 및 당뇨병 등 치명적인 질병을 야기한다. 이는 순환기계 질병의 원인이 되는 동시에 상기 질병들과 합병증으로 나타날 경우 치사율이 매우 높은 만성퇴행성 질환으로 발전하게 된다. 고혈압과 관련하는 앤지오텐신 전환효소(angiotensin converting enzyme, ACE)는 아연금속 프로테아제(protease) 그룹에 속하고 폐혈관 내피를 감싸고 있다. 앤지오텐신(angiotensin)은 10개의 아미노산 잔기로 구성된 펩타이드(peptide)로서, 앤지오텐시노겐(angiotensinogen)이 레닌(renin)에 의해 분해되어 생성되며, 이것은 ACE에 의해서 C말단의 디펩타이드(dipeptide, His-Leu)가 절단되어 8개의 펩타이드(peptide)를 갖는 강력한 혈관 수축물질인 앤지오텐신(angiotensin)이 생성된다. 앤지오텐신(angiotensin)은 동맥혈관을 수축시키고 혈압을 상승시켜, 아드레날에서의 알도스테론(aldosterone)의 분비를 촉진하여 신장의 나트륨(sodium) 및 수분의 재흡수를 증가시키는 역할을 한다. 또한 ACE는 혈관확장, 장의 운동성 증대 등의 작용을 갖는 브래디키닌(bradykinin)을 분해하여 불활성화시킴으로써 결과적으로 혈압을 상승시키는 역할을 한다. 특히, ACE에 의해 혈관수축물질이 생성되어 고혈압을 유발하게 되므로 이와 같은 혈관수축물질 제어물질로 캡토프릴(captopril) 등과 같은 화학적 합성 치료제들은 다양한 부작용이 나타나기 때문에 천연물 유래의 ACE 저해제를 찾는 데 많은 관심이 집중되고 있다.Hypertension is a disease that affects 15-20% of adults worldwide, causing fatal diseases such as atherosclerosis, stroke, myocardial infarction and diabetes. This causes a circulatory disease and at the same time develops a chronic degenerative disease with a high mortality rate when complications with the above diseases occur. Angiotensin converting enzyme (ACE), which is associated with hypertension, belongs to the zinc metal protease group and surrounds the pulmonary vascular endothelium. Angiotensin is a peptide consisting of 10 amino acid residues. Angiotensinogen is decomposed by renin and is produced by ACE. His-Leu) is cleaved to produce angiotensin, a potent vasoconstrictor with eight peptides. Angiotensin constricts arterial vessels and raises blood pressure, thereby promoting the release of aldosterone from the adrenaline, thereby increasing resorption of sodium and water in the kidneys. In addition, ACE decomposes and inactivates bradykinin, which has effects such as vasodilation and increased intestinal motility, and consequently increases blood pressure. In particular, since ACE is produced by ACE and causes hypertension, chemical synthetic therapeutic agents such as captopril have various side effects as control agents for vascular shrinkage, and therefore, there is much interest in finding ACE inhibitors derived from natural products. This is concentrated.
활성산소를 제거시키거나 유리라디칼 생성을 억제하는 항산화 물질들은 과량 생성된 활성산소에 의해 발생한 각종 질병의 예방 및 치료와 피부 노화억제를 목적으로 이용되고 있다. 현재 사용되고 있는 항산화제로는 t-부틸하이드록시톨루엔(BHT), t-부틸하이드록시아니솔(BHA) 등의 합성 항산화제와 토코페롤(tocopherol), 카로티노이드, 플라보노이드(flavonoid), 탄닌 등의 천연 항산화제 및 SOD와 같은 항산소성 효소 등이 사용되고 있다. 합성 항산화제는 인체에 대한 독성과 비싼 가격 등의 문제로 사용에 제한을 받고 있으므로, 인체에 무해하면서도 더욱 강한 항산화효과를 나타내는 천연 항산화제 및 천연식품의 개발이 절실히 요구되고 있다.Antioxidants that remove free radicals or inhibit free radical production are used for the prevention and treatment of various diseases caused by excessively produced free radicals and to inhibit skin aging. Currently used antioxidants include synthetic antioxidants such as t-butylhydroxytoluene (BHT) and t-butylhydroxyanisole (BHA), and natural antioxidants such as tocopherol, carotenoid, flavonoid and tannin. And antioxidant enzymes such as SOD are used. Since synthetic antioxidants are limited in use due to toxicity and high price of the human body, there is an urgent need for the development of natural antioxidants and natural foods, which are harmless to the human body and exhibit stronger antioxidant effects.
한국특허공개 제2010-0122697호에는 미나리효소액 제조방법이 개시되어 있으나, 본 발명의 항산화 및 항고혈압 활성이 증진된 산야초 유산발효액과는 상이하다.Korean Patent Publication No. 2010-0122697 discloses a method for preparing a buttercup enzyme solution, which is different from the acidic lactobacillus fermentation broth with enhanced antioxidant and antihypertensive activity of the present invention.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명의 목적은 산야초의 항산화 또는 항고혈압 활성을 증진시키기 위해, 산야초에 유산균을 이용하여 일정한 조건에서 발효시킴으로써 항산화 또는 항고혈압 활성이 증진될 뿐만 아니라 관능적으로 우수한 산야초 유산발효액을 유효성분으로 함유하는 조성물을 제공하는 데 있다.The present invention is derived from the above requirements, the object of the present invention is to enhance the antioxidant or antihypertensive activity by fermentation under certain conditions using lactic acid bacteria in Sanyacho to enhance the antioxidant or antihypertensive activity of Sanyacho. But it is to provide a composition containing a sensory excellent acid Yachi lactic acid fermentation as an active ingredient.
상기 과제를 해결하기 위해, 본 발명은 쑥 및 취나물로 이루어진 군으로부터 선택되는 하나 이상의 산야초의 유산발효액을 유효성분으로 함유하는 항산화 활성 증진용 조성물을 제공한다.In order to solve the above problems, the present invention provides a composition for enhancing antioxidant activity containing lactic acid fermentation of at least one wild grass selected from the group consisting of mugwort and wormwood as an active ingredient.
또한, 본 발명은 미나리의 유산발효액을 유효성분으로 함유하는 항고혈압 활성 증진용 조성물을 제공한다.The present invention also provides a composition for enhancing antihypertensive activity containing lactic acid fermentation broth as an active ingredient.
또한, 본 발명은 상기 항산화 활성 증진용 조성물을 유효성분으로 함유하는 항산화 활성 증진용 식품을 제공한다.The present invention also provides an antioxidant activity-enhancing food containing the antioxidant activity-enhancing composition as an active ingredient.
또한. 본 발명은 상기 항고혈압 활성 증진용 조성물을 유효성분으로 함유하는 항고혈압 활성 증진용 식품을 제공한다.Also. The present invention provides an antihypertensive activity enhancing food containing the antihypertensive activity enhancing composition as an active ingredient.
본 발명의 산야초에 유산균을 접종한 후 발효시킨 유산발효액은 자연발효 또는 효모와 유산균을 이용하여 발효시킨 발효액에 비해 항산화 또는 항고혈압 활성이 증진되며, 식물로부터 얻어진 물질을 함유하기 때문에 부작용을 일으키지 않으므로, 항산화 또는 항고혈압 활성을 증진시키기 위한 건강 지향의 기능성 식품에 효과적으로 쓰일 수 있으며, 이를 통해 농가의 생산력 향상 및 부가가치 증대를 기대할 수 있다.Lactic acid fermentation broth fermented after inoculating lactic acid bacteria to wild vinegar of the present invention is enhanced in antioxidant or antihypertensive activity compared to fermentation broth fermented with natural fermentation or yeast and lactic acid bacteria, and does not cause side effects because it contains substances obtained from plants In addition, it can be effectively used in health-oriented functional foods to promote antioxidant or antihypertensive activity, thereby improving the productivity of farmers and increasing the added value.
도 1은 쑥과 취나물(취)의 자연발효구, 유산균 접종구 및 효모 유산균 접종구의 항산화 활성을 전자공여능으로 측정한 것이다.
도 2는 미나리의 자연발효구, 유산균 접종구 및 효모 유산균 접종구의 항고혈압 활성을 앤지오텐신 전환효소(angiotensin converting enzyme, ACE) 저해활성으로 측정한 것이다.
도 3은 미나리의 자연발효구, 유산균 접종구 및 효모 유산균 접종구를 비교하여 수행한 관능평가와 미나리 시제품(유산균 접종구)과 미나리 시장제품을 비교하여 수행한 관능평가 결과를 나타낸 것이다.Figure 1 is a measure of the antioxidant activity of the mugwort and wormwood (smelling) spontaneous fermentation, lactic acid bacteria inoculation and yeast lactic acid bacteria inoculation.
Figure 2 is the antihypertensive activity of the natural fermentation, Lactobacillus inoculation and yeast lactic acid inoculation of the buttercup is measured by angiotensin converting enzyme (ACE) inhibitory activity.
Figure 3 shows the sensory evaluation performed by comparing the natural fermentation, lactic acid bacteria inoculation and yeast lactic acid bacteria inoculation of buttercups and sensory evaluation results by comparing the buttercup prototype (Lactobacillus inoculation) and buttercup market products.
본 발명의 목적을 달성하기 위하여, 본 발명은 쑥 및 취나물로 이루어진 군으로부터 선택되는 하나 이상의 산야초에 유산균을 접종한 후 발효시켜 제조된 유산발효액을 유효성분으로 함유하는 항산화 활성 증진용 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a composition for enhancing antioxidant activity containing a lactic acid fermentation broth prepared by inoculating and fermenting lactic acid bacteria into one or more wild grasses selected from the group consisting of mugwort and wormwood as an active ingredient. .
또한, 본 발명은 미나리에 유산균을 접종한 후 발효시켜 제조된 유산발효액을 유효성분으로 함유하는 항고혈압 활성 증진용 조성물을 제공한다.In another aspect, the present invention provides a composition for enhancing antihypertensive activity containing a lactic fermentation broth prepared by fermentation after inoculating lactic acid bacteria in buttercup as an active ingredient.
본 발명의 조성물에서, 상기 유산균은 락토바실러스 플란타룸(Lactobacillus plantarum)일 수 있으나, 이에 제한되지 않는다.In the composition of the present invention, the lactic acid bacteria is Lactobacillus plantarum ( Lactobacillus plantarum ), but is not limited thereto.
본 발명의 항산화 활성 증진용 조성물에서 유산발효액의 제조방법은The production method of lactic acid fermentation solution in the composition for enhancing antioxidant activity of the present invention
(a) 쑥 및 취나물로 이루어진 군으로부터 선택되는 하나 이상의 산야초 46~52 중량부에 설탕 46~52 중량부를 혼합하여 혼합물을 제조하는 단계; 및(a) preparing 46-52 parts by weight of sugar to 46-52 parts by weight of one or more wild vegetables selected from the group consisting of mugwort and wormwood to prepare a mixture; And
(b) 상기 (a)단계의 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum) 1~3 중량부를 접종하여 20~30℃에서 30~90일 동안 발효하는 단계를 포함할 수 있으며,(b) inoculating 1 to 3 parts by weight of Lactobacillus plantarum ( Lactobacillus plantarum ) in the mixture of step (a) may include the step of fermentation at 20 ~ 30 ℃ for 30 to 90 days,
바람직하게는Preferably
(a) 쑥 및 취나물로 이루어진 군으로부터 선택되는 하나 이상의 산야초 49 중량부에 설탕 49 중량부를 혼합하여 혼합물을 제조하는 단계; 및(a) mixing 49 parts by weight of sugar with 49 parts by weight of one or more wild vegetables selected from the group consisting of mugwort and wormwood to prepare a mixture; And
(b) 상기 (a)단계의 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum) 2 중량부를 접종하여 25℃에서 90일 동안 발효하는 단계를 포함할 수 있다.(b) inoculating 2 parts by weight of Lactobacillus plantarum ( Lactobacillus plantarum ) in the mixture of step (a) may comprise the step of fermentation for 90 days at 25 ℃.
또한 본 발명의 항고혈압 활성 증진용 조성물에서 유산발효액의 제조방법은In addition, the preparation method of the lactic acid fermentation solution in the composition for enhancing antihypertensive activity of the present invention
(a) 미나리 46~52 중량부에 설탕 46~52 중량부를 혼합하여 혼합물을 제조하는 단계; 및(a) 46-52 parts by weight of sugar buttercups 46-52 parts by weight to prepare a mixture; And
(b) 상기 (a)단계의 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum) 1~3 중량부를 접종하여 20~30℃에서 30~90일 동안 발효하는 단계를 포함할 수 있으며,(b) inoculating 1 to 3 parts by weight of Lactobacillus plantarum ( Lactobacillus plantarum ) in the mixture of step (a) may include the step of fermentation at 20 ~ 30 ℃ for 30 to 90 days,
바람직하게는Preferably
(a) 미나리 49 중량부에 설탕 49 중량부를 혼합하여 혼합물을 제조하는 단계;(a) mixing 49 parts by weight of sugar to 49 parts by weight of buttercup to prepare a mixture;
(b) 상기 (a)단계의 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum) 2 중량부를 접종하여 25℃에서 90일 동안 발효하는 단계를 포함할 수 있다.(b) inoculating 2 parts by weight of Lactobacillus plantarum ( Lactobacillus plantarum ) in the mixture of step (a) may comprise the step of fermentation for 90 days at 25 ℃.
본 발명은 또한, 상기 항산화 활성 증진용 조성물을 유효성분으로 함유하는 항산화 활성 증진용 식품을 제공한다.The present invention also provides an antioxidant activity enhancing food containing the composition for enhancing antioxidant activity as an active ingredient.
본 발명은 또한, 상기 항고혈압 활성 증진용 조성물을 유효성분으로 함유하는 항고혈압 활성 증진용 식품을 제공한다.The present invention also provides an antihypertensive activity enhancing food containing the antihypertensive activity enhancing composition as an active ingredient.
상기 식품은 항산화 또는 항고혈압 활성을 증가시키기 위해 섭취할 수 있는 것이면 특별히 제한되지 않는다.The food is not particularly limited as long as it can be ingested to increase antioxidant or antihypertensive activity.
본 발명의 상기 조성물을 식품첨가물로 사용하는 경우, 상기 조성물을 그대로 첨가하거나 다른 식품 또는 식품 성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효 성분의 혼합양은 그의 사용 목적(예방, 건강 또는 치료적 처치)에 따라 적합하게 결정될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 발명의 조성물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양으로 첨가된다. 그러나, 건강 및 위생을 목적으로 하거나 또는 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 상기 양은 상기 범위 이하일 수 있으며, 안전성 면에서 아무런 문제가 없기 때문에 유효성분은 상기 범위 이상의 양으로도 사용될 수 있다.When the composition of the present invention is used as a food additive, the composition may be added as it is or used with other food or food ingredients, and may be appropriately used according to a conventional method. The amount of the active ingredient to be mixed can be suitably determined according to its intended use (prevention, health or therapeutic treatment). Generally, in the preparation of food or beverages, the composition of the present invention is added in an amount of up to 15 parts by weight, preferably up to 10 parts by weight based on the raw materials. However, in the case of long-term intake for health and hygiene or health control, the amount may be below the above range, and the active ingredient may be used in an amount above the above range because there is no problem in terms of safety. .
상기 식품의 종류에는 특별한 제한은 없다. 상기 조성물을 첨가할 수 있는 식품의 예로는 육류, 소세지, 빵, 쵸코렛, 캔디류, 스넥류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차, 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다.There is no particular limitation on the kind of the food. Examples of the food to which the composition may be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, dairy products including other noodles, gum, ice cream, various soups, beverages, teas, drinks, Alcoholic beverages and vitamin complexes, and the like and include all of the health foods in the conventional sense.
본 발명의 건강음료 조성물은 통상의 음료와 같이 여러 가지 향미제 또는 천연 탄수화물 등을 추가 성분으로서 함유할 수 있다. 상술한 천연 탄수화물은 포도당, 과당과 같은 모노사카라이드, 말토스, 슈크로스와 같은 디사카라이드, 및 덱스트린, 사이클로덱스트린과 같은 폴리사카라이드, 자일리톨, 소르비톨, 에리트리톨 등의 당알콜이다. 감미제로서는 타우마틴, 스테비아 추출물과 같은 천연 감미제나, 사카린, 아스파르탐과 같은 합성 감미제 등을 사용할 수 있다. 상기 천연탄수화물의 비율은 본 발명의 조성물 100 ㎖당 일반적으로 약 0.01~0.04 g, 바람직하게는 약 0.02~0.03 g 이다.The health beverage composition of the present invention may contain various flavors or natural carbohydrates as an additional ingredient such as ordinary beverages. Such natural carbohydrates are monosaccharides such as glucose and fructose, disaccharides such as maltose and sucrose, and polysaccharides such as dextrin and cyclodextrin, and sugar alcohols such as xylitol, sorbitol and erythritol. Examples of sweeteners include natural sweeteners such as tau martin and stevia extract, synthetic sweeteners such as saccharin and aspartame, and the like. The ratio of the natural carbohydrate is generally about 0.01 to 0.04 g, preferably about 0.02 to 0.03 g per 100 ml of the composition of the present invention.
상기 외에 본 발명의 조성물은 여러 가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 함유할 수 있다. 그 밖에 본 발명의 조성물은 천연 과일쥬스, 과일쥬스 음료 및 야채 음료의 제조를 위한 과육을 함유할 수 있다. 이러한 성분은 독립적으로 또는 혼합하여 사용할 수 있다. 이러한 첨가제의 비율은 크게 중요하진 않지만 본 발명의 조성물 100 중량부당 0.01~0.1 중량부의 범위에서 선택되는 것이 일반적이다.
In addition to the above, the composition of the present invention includes various nutrients, vitamins, electrolytes, flavors, coloring agents, pectic acid and salts thereof, alginic acid and salts thereof, organic acids, protective colloidal thickeners, pH adjusting agents, stabilizers, preservatives, glycerin, alcohols, And carbonating agents used in carbonated drinks. In addition, the composition of the present invention may contain a pulp for the production of natural fruit juices, fruit juice drinks and vegetable drinks. These components may be used independently or in combination. The proportion of such additives is not critical but is usually selected in the range of 0.01 to 0.1 parts by weight per 100 parts by weight of the composition of the present invention.
이하, 본 발명을 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.
Hereinafter, the present invention will be described in detail by way of examples. However, the following examples are illustrative of the present invention, and the present invention is not limited to the following examples.
가. 재료end. material
쑥과 취나물은 충청남도 태안군, 미나리는 전라남도 나주시에서 2010년 4월에 각각 구입하여 사용하였으며, 황설탕은 시판되는 S사 제품을 사용하였다.
Mugwort and wormwood were purchased and used in April 2010 from Taean-gun, Chungcheongnam-do, and Na-na, Jeollanam-do, respectively.
나. 발효액 제조방법I. Fermentation broth production method
쑥, 취나물 또는 미나리를 세척 후 물기를 제거하고, 10 cm 내외로 절단하였다. 상기 절단된 쑥, 취나물 또는 미나리와 황설탕을 1:1의 비율로 무게를 달아 황설탕의 80%를 쑥, 취나물 또는 미나리와 버무려 항아리(Imsil, Korea)에 담금 후, 나머지 설탕은 표면 위를 덮는데 사용하였다. 그리고 하기 표 1과 같이 자연발효구, 유산균 접종구 및 효모 유산균 접종구로 나누어 각각 처리하였고, 항아리 입구를 비닐로 묶어 공기를 차단시켰다. 항아리를 25℃가 유지되는 항온 항습실에 넣어 90일 동안 발효를 진행시켰다.Mugwort, herbs or buttercups were washed and then drained, cut into 10 cm or so. Weigh the cut mugwort, ragweed or buttercup and brown sugar in a ratio of 1: 1, soak 80% of the yellow sugar in a jar (Imsil, Korea) with mugwort, ragweed or buttercup, and rest the sugar on the surface. Used to cover. Then, as shown in Table 1, each treatment was divided into natural fermentation, lactic acid bacteria inoculation and yeast lactic acid bacteria inoculation, and the jar inlet was bound with vinyl to block the air. The jars were placed in a constant temperature and humidity chamber maintained at 25 ° C. and fermented for 90 days.
(Lactbacillus plantarum JBMI F3 culture)Lactobacillus plantarum
( Lactbacillus plantarum JBMI F3 culture)
(Saccharomyces cerevisiae ATCC 20252 culture)Saccharomyces cerevisiae
( Saccharomyces cerevisiae ATCC 20252 culture)
유산균(Lactic acid bacteria, LAB)은 (재)전주생물소재연구소에서 분리동정한 락토바실러스 플란타룸(Lactobacillus plantarum JBMI F3)을 MRS broth(Difco, USA)에 접종하고 30℃에서 24시간 2회 계대 배양 후 사용하였고, 효모는 사카로마이세스 세레비지애(Saccharomyces cerevisiae ATCC 20252)를 LB broth(Difco, USA)에 접종하고, 25℃에서 24시간 2회 계대 배양 후 스타터(starter)로 사용하였다.
Lactic acid bacteria (Lactic acid bacteria, LAB) is (re) Jeonju biological material Lanta by Lactobacillus separate sample identified in the laboratory room (Lactobacillus plantarum JBMI F3) was inoculated in MRS broth (Difco, USA) and used after passage for 24 hours twice at 30 ° C. Yeast was used in Saccharomyces cerevisiae ATCC 20252) was inoculated in LB broth (Difco, USA) and used as a starter after two passages at 25 ° C. for 24 hours.
다. 발효액의 항산화 활성All. Antioxidant Activity of Fermentation Broth
발효액에 증류수를 가하여 5배 희석 후 원심분리(4,000 rpm, 10분, 4℃)한 상등액을 분석시료로 사용하였다. 항산화활성은 Sultana 등의 방법에 따라 DPPH 라디칼 소거능(DPPH radical scavenging activity)을 측정하였다. 즉, 5배 희석한 발효액 상등액을 0.1 mM DPPH 용액과 1:1로 섞어 최종적으로 10배 희석액으로 제조하였다. 상기 희석액을 37℃에서 30분 동안 반응시킨 후, 517 nm 파장에서 흡광도를 측정하고 시료 무첨가 대조구와 비교하여 아래 식에 의하여 라디칼 소거능(radical scavenging activity)을 산출하였다. 아스코르브산(ascorbic acid)은 항산화능 비교물질로 에탄올에 녹여 10 ug/ml로 만들어 상기와 동일한 방법으로 처리하여 항산화능을 비교하였다.Distilled water was added to the fermentation broth and diluted 5 times, followed by centrifugation (4,000 rpm, 10 minutes, 4 ° C). Antioxidant activity was measured by the method of Sultana et al. DPPH radical scavenging activity. That is, the fermentation broth super diluted five-fold was mixed 1: 1 with 0.1 mM DPPH solution to finally prepare a 10-fold dilution. After reacting the dilution solution at 37 ° C. for 30 minutes, absorbance at 517 nm was measured and the radical scavenging activity was calculated by the following equation compared with the sample-free control. Ascorbic acid (Ascorbic acid) is an antioxidant comparable substance was dissolved in ethanol to 10 ug / ml and treated in the same manner as above to compare the antioxidant capacity.
DPPH 자유 라디칼 소거능(DPPH free radical scavenging activity, %)DPPH free radical scavenging activity (%)
=(1-(A-B/C))×100= (1- (A-B / C)) × 100
A: 샘플추출액과 DPPH를 반응시킨 후 흡광도A: Absorbance after reacting the sample extract with DPPH
B: 샘플추출액과 에탄올을 반응시킨 후 흡광도B: Absorbance after reacting sample extract with ethanol
C: 에탄올과 DPPH를 반응시킨 후 흡광도
C: absorbance after reacting ethanol and DPPH
라. 발효액의 항고혈압 활성 la. Antihypertensive Activity of Fermentation Broth
항고혈압 활성은 앤지오텐신 전환효소(angiotensin converting enzyme, ACE) 의 저해활성을 Shon 등의 방법에 의해 측정하여 ACE 저해율로 표시하였다. 0.3M NaCl을 함유한 0.1M 인산칼륨 버퍼(potassium phosphate buffer, pH 8.3)에 토끼 폐(rabbit lung) 아세톤 분말(Sigma, USA)을 1 g/20 ml(w/v)의 농도로 4℃에서 24시간 동안 추출한 후, 원심분리(5,000 rpm, 10분, 4℃)하여 ACE 조효소액을 얻었다. 양성 대조구로서 캡토프릴(Biochemika, U.S.A.)과 시료에 0.1M 인산칼륨 버퍼(potassium phosphate buffer, pH 8.3) 100 ul와 ACE 조효소액 100 ul를 가해 5분간 예비반응을 시킨 후, HHL(hippuryl-histidyl-leucine) 5 mg/ml 용액을 50 ul을 가한 다음 37℃에서 30분간 반응시켰다. 여기에 1N HCl 300 ul을 첨가하여 반응을 정지시킨 후, 에틸아세테이트(ethyl acetate) 1 ml을 가해 30초 동안 교반하고, 4℃에서 30분간 정치시켰다. 이를 원심분리(5,000 rpm, 10분, 4℃)하여 상등액 500 ul을 얻었다. 이 상등액을 99℃, 30분간 가열하여 완전히 건조시킨 후, 1 ml의 증류수를 가하고 228 nm에서 흡광도를 측정하여 ACE 저해활성을 측정하였다. 대조구는 추출용매를 동량 가해 실험하였으며, ACE 저해활성은 다음 식에 의하여 산출하였다.Antihypertensive activity was expressed by the inhibition rate of angiotensin converting enzyme (ACE) by Shon et al. Rabbit lung acetone powder (Sigma, USA) in 0.1 M potassium phosphate buffer (pH 8.3) containing 0.3 M NaCl at a concentration of 1 g / 20 ml (w / v) at 4 ° C. After extracting for 24 hours, centrifugation (5,000 rpm, 10 minutes, 4 ℃) to obtain the ACE coenzyme solution. As a positive control, 100 ul of 0.1 M potassium phosphate buffer (pH 8.3) and 100 ul of ACE coenzyme solution were added to captopril (Biochemika, USA) and the sample, followed by preliminary reaction for 5 minutes, followed by HHL (hippuryl-histidyl-). leucine) 5 mg / ml solution was added 50 ul and then reacted at 37 ℃ for 30 minutes. After the reaction was stopped by adding 300 ul of 1N HCl, 1 ml of ethyl acetate was added thereto, stirred for 30 seconds, and left at 4 ° C. for 30 minutes. This was centrifuged (5,000 rpm, 10 minutes, 4 ℃) to obtain a supernatant 500 ul. The supernatant was heated to 99 ° C. for 30 minutes and completely dried. Then, 1 ml of distilled water was added and absorbance was measured at 228 nm to measure ACE inhibitory activity. The control group was tested by the same amount of the extraction solvent, the ACE inhibitory activity was calculated by the following equation.
ACE 저해활성(%)=(1-발효액 흡광도/대조구 흡광도)×100
ACE inhibitory activity (%) = (1-fermented liquid absorbance / control absorbance) × 100
마. 관능평가hemp. Sensory evaluation
관능평가는 훈련된 10명을 선발하여 진행하였다. 먼저 미나리 발효액:정제수 = 1:3의 비율로 희석한 음료를 대상으로 관능검사를 수행하였다. 미나리의 자연발효구, 유산균 접종구 및 효모유산균 접종구와 비교하여 기호도가 높은 1종을 선별하였고, 이를 미나리 시장제품과 비교하였다. 관능평가는 7점 척도법(7: 아주 좋음, 4: 보통, 1: 아주 나쁨)으로 평가하였다.
The sensory evaluation was conducted with 10 trained participants selected. First, sensory tests were performed on beverages diluted in a buttercup fermentation broth: purified water = 1: 3. Compared with the natural fermentation, Lactobacillus inoculation, and yeast lactic acid inoculation of buttercup, one species with high preference was selected and compared with the buttercup market product. Sensory evaluation was performed on a 7-point scale (7: very good, 4: moderate, 1: very bad).
실시예Example 1: 항산화 활성 1: antioxidant activity
본 실험에서는 DPPH법을 이용하여 항산화능을 측정하였다. 그 결과 쑥 발효액과 취나물 발효액에서 유산균 접종구가 자연발효구나 효모 유산균 접종구에 비해 항산화 활성이 높게 나타났다(도 1).
In this experiment, antioxidant activity was measured using DPPH method. As a result, the intake of lactic acid bacteria in the mugwort fermentation broth and broth fermentation broth showed higher antioxidant activity than the natural fermentation or yeast lactobacillus inoculation (FIG. 1).
실시예Example 2: 항고혈압 활성 2: antihypertensive activity
본 실험에서는 앤지오텐신 전환효소(angiotensin converting enzyme, ACE) 저해활성을 측정하여 항고혈압 활성을 평가하였다(도 2). 양성대조군으로 사용한 캡토프릴(captopril) 200 ug/ml는 ACE의 강력한 저해제 중 하나로서 48%의 ACE 저해율을 나타내었다. 그리고 미나리 발효액의 ACE 저해활성은 25~60% 범위를 나타내었으며, 미나리 발효액 중 유산균 접종구가 60%의 ACE 저해율을 나타내어, 자연발효구와 효모 유산균 접종구에 비해 높은 ACE 저해율을 나타내었다.
In this experiment, antihypertensive activity was evaluated by measuring angiotensin converting enzyme (ACE) inhibitory activity (FIG. 2). Captopril (200 ug / ml) used as a positive control was one of the potent inhibitors of ACE, showing an ACE inhibition rate of 48%. The ACE inhibitory activity of the buttercup fermentation broth was in the range of 25-60%, and the lactobacillus inoculation showed a 60% ACE inhibition rate in the buttercup fermentation broth, indicating higher ACE inhibition rate compared to the natural fermentation and yeast lactobacillus.
실시예Example 3: 관능평가 3: sensory evaluation
미나리 발효액의 관능평가는 7점 척도법을 사용하여 기호성을 평가하였다(도 3). 미나리의 자연발효구, 유산균 접종구 및 효모 유산균 접종구를 비교하여 관능평가를 수행한 결과, 색, 단향, 신향, 단맛, 신맛 및 전체적인 기호도에서 미나리 유산균 접종구가 5~6점대의 높은 점수를 얻어, 자연발효구와 효모 유산균 접종구에 비해 높은 기호도를 나타내었다.The sensory evaluation of the buttercup fermentation broth evaluated the palatability using a 7-point scale method (FIG. 3). Sensory evaluation was performed by comparing the natural fermentation, Lactobacillus inoculation and yeast lactobacillus inoculations of buttercups, and the results showed that the buttercup lactobacillus inoculation group scored 5-6 points in color, sweetness, freshness, sweetness, sourness and overall preference. The degree of preference was higher than that of natural fermentation and yeast lactic acid bacteria inoculation.
또한, 미나리 시제품(유산균 접종구)과 미나리 시장제품을 비교한 결과, 향에 대한 선호도 차이는 거의 없었으나, 단맛(sweet taste)과 신맛(sour taste)에 대한 선호도에서 2점대의 차이를 보이며 본 발명의 미나리 유산균 접종구가 높은 기호도를 나타내었으며, 전체적인 기호도에서도 미나리 유산균 접종구가 미나리 시장제품에 비해 우수한 점수를 얻었다.In addition, as a result of comparing the buttercup prototype (lactic acid bacterium inoculation) and the buttercup market product, there was almost no difference in the preference for flavor, but it showed a difference of two points in the preference for sweet taste and sour taste. Buttercup lactobacillus inoculation of the invention showed a high degree of acceptance, even in the overall preference of the buttercup lactobacillus inoculation obtained excellent scores compared to the buttercup market products.
Claims (7)
(a) 쑥 및 취나물로 이루어진 군으로부터 선택되는 하나 이상의 산야초 46~52 중량부에 설탕 46~52 중량부를 혼합하여 혼합물을 제조하는 단계; 및
(b) 상기 (a)단계의 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum) 1~3 중량부를 접종하여 20~30℃에서 30~90일 동안 발효하는 단계에 의해 제조되는 것을 특징으로 하는 조성물.According to claim 1, wherein the lactic acid fermentation liquid
(a) preparing 46-52 parts by weight of sugar to 46-52 parts by weight of one or more wild vegetables selected from the group consisting of mugwort and wormwood to prepare a mixture; And
(b) 1 to 3 parts by weight of Lactobacillus plantarum ( Lactobacillus plantarum ) to the mixture of step (a) by inoculating 1 to 3 parts by weight of the composition, characterized in that it is prepared by the step of fermentation for 30 to 90 days at 20-30 ℃.
(a) 미나리 46~52 중량부에 설탕 46~52 중량부를 혼합하여 혼합물을 제조하는 단계; 및
(b) 상기 (a)단계의 혼합물에 락토바실러스 플란타룸(Lactobacillus plantarum) 1~3 중량부를 접종하여 20~30℃에서 30~90일 동안 발효하는 단계에 의해 제조되는 것을 특징으로 하는 조성물.According to claim 2, wherein the lactic acid fermentation liquid
(a) 46-52 parts by weight of sugar buttercups 46-52 parts by weight to prepare a mixture; And
(b) 1 to 3 parts by weight of Lactobacillus plantarum ( Lactobacillus plantarum ) to the mixture of step (a) by inoculating 1 to 3 parts by weight of the composition, characterized in that it is prepared by the step of fermentation for 30 to 90 days at 20-30 ℃.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100133670A KR20120071932A (en) | 2010-12-23 | 2010-12-23 | Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100133670A KR20120071932A (en) | 2010-12-23 | 2010-12-23 | Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20120071932A true KR20120071932A (en) | 2012-07-03 |
Family
ID=46706809
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100133670A KR20120071932A (en) | 2010-12-23 | 2010-12-23 | Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20120071932A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101301546B1 (en) * | 2013-07-24 | 2013-08-30 | 오태경 | Functional fermentation composition having anti-inflammatory effect of fermented mixed plants(wild plant dln-28) using sugar-free fermentation |
KR101402599B1 (en) * | 2012-12-31 | 2014-06-03 | 재단법인 경기과학기술진흥원 | Composition comprising saussurea pulchella fisch for preventing and treating allergy disease |
KR20190004918A (en) | 2017-07-05 | 2019-01-15 | 한국식품연구원 | Fraction of fermented product using omeginuruk having antioxidative, antihypertensive and whitening activity and method of preparing the same |
KR102092310B1 (en) * | 2018-10-15 | 2020-03-23 | 마옥천 | manufacturing method of seaweed fulvescens snack and seaweed fulvescens snack manufactured using the same |
KR102475323B1 (en) * | 2022-06-20 | 2022-12-07 | 주식회사 비에스에프앤씨 | Fermented wild herbs which can be added in salad dressing |
-
2010
- 2010-12-23 KR KR1020100133670A patent/KR20120071932A/en active IP Right Grant
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101402599B1 (en) * | 2012-12-31 | 2014-06-03 | 재단법인 경기과학기술진흥원 | Composition comprising saussurea pulchella fisch for preventing and treating allergy disease |
KR101301546B1 (en) * | 2013-07-24 | 2013-08-30 | 오태경 | Functional fermentation composition having anti-inflammatory effect of fermented mixed plants(wild plant dln-28) using sugar-free fermentation |
KR20190004918A (en) | 2017-07-05 | 2019-01-15 | 한국식품연구원 | Fraction of fermented product using omeginuruk having antioxidative, antihypertensive and whitening activity and method of preparing the same |
KR102092310B1 (en) * | 2018-10-15 | 2020-03-23 | 마옥천 | manufacturing method of seaweed fulvescens snack and seaweed fulvescens snack manufactured using the same |
KR102475323B1 (en) * | 2022-06-20 | 2022-12-07 | 주식회사 비에스에프앤씨 | Fermented wild herbs which can be added in salad dressing |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20070012589A (en) | Mushroom beverage manufacture and the method | |
KR20120071932A (en) | Lactic acid fermented solution of wild plant with enhanced antioxidative and antihypertensive activity | |
KR101663379B1 (en) | MANUFACTURE OF FERMENTED Allium hookeri FROM YEASTS AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST | |
KR101024238B1 (en) | The manufacturing method of vinegar using mainly Gastrodia elata Blume, and its product | |
KR102139951B1 (en) | Manufacturing method for seasoned ribs of pork and seasoned ribs of pork manufactured by the same | |
KR100768830B1 (en) | Extract of echinosophora koreensis removing hangover and having anti-oxidant activity | |
JP3618653B2 (en) | Pharmacological composition having blood pressure lowering effect | |
KR100536083B1 (en) | Mixture of pine tree leaves supernatant juice fermentation solution and Lespedeza cuneate G. Don extract and health food containing the same | |
KR102342814B1 (en) | Composition containing an fermented extract of protaetia brevitarsis seulensis as an active ingredient and manufacturing the same | |
KR20120000382A (en) | Salt using bambusae calulis in liquamen and functional food composition | |
KR102444816B1 (en) | Preparing method of the functional rice paste using mulberry leaves, mulberry and glutinous rice | |
KR102636322B1 (en) | Method for manufacturing dried yellow corvina with gochujang and dried yellow corvina with gochujang produced thereby | |
KR102543221B1 (en) | Method for manufacturing seasoning sauce using fermented onion and seasoning sauce prepared thereby | |
KR102489041B1 (en) | Production method of low salt napa cabbage kimchi using functional spice | |
KR102616727B1 (en) | Method of manufacturing high-protein phellinus linteus alcoholic drinks and phellinus linteus alcoholic drinks manufactured by the same | |
KR102649148B1 (en) | Manufacturing method of pollack pack for cooking and pollack pack manufactured by the same | |
KR102621081B1 (en) | Method for manufacturing seasoning sauce for shellfish and seafood | |
KR102262551B1 (en) | Manufacturing Method of Soup using Chicken Breast and Soup Composition using Chicken Breast | |
KR102200920B1 (en) | Method for manufacturing health pickled radish using green tea, mulberry leaves and health pickled radish using turmeric manufactured by the same | |
KR101806872B1 (en) | Kimchi Seasoning Composition for Improvement of Skin Beauty And Antioxidative Activity and Functional Kimchi Containing Thereof | |
KR101327469B1 (en) | Anti-oxident wild-garlic beverage and manufacturing method thereof | |
KR20200137351A (en) | Method for Manufacturing Allium hookeri Powder | |
KR20040064363A (en) | Functional dried fishes containing diet enzyme, herb medicines and functional materials | |
KR20040063681A (en) | Functional kimchi | |
KR20040064399A (en) | Functional sausage containing diet enzyme, herb medicines and functional materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right |